Neupulse

St Andrews-based investment firm Eos Advisory has led a £2.5 million investment into Neupulse, a start-up developing the world's first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialisation. Neupulse’s recently finalised working protot